Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron
Status:
Completed
Trial end date:
2009-07-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics of three doses of oral mirabegron
formulations with three different release rates versus three doses of mirabegron administered
intravenously; to study safety and side effects of the oral and IV doses of mirabegron.